

HY-14575 · 50 mg
MedChemExpress · Cat: HY-14575
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/nastorazepide-hemicalcium.html
Description
Nastorazepide Z-360 hemicalcium is an orally active 1,5-benzodiazepine derivative and gastrin/CCK-2 receptor antagonist. Nastorazepide hemicalcium inhibits the specific binding of 3H CCK-8 to the human CCK-2 receptor with a Ki value of 0.47 nM. Nastorazepide hemicalcium inhibits IL-1?, ephrin B1, VEGF, and HIF-1alpha, reduces Akt and NR2B phosphorylation. Nastorazepide hemicalcium has antitumor activity against pancreatic cancer. Nastorazepide hemicalcium inhibits colorectal cancer liver metastasis and relieves pain.







